↓ Skip to main content

Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency

Overview of attention for article published in Journal of Clinical Oncology, March 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
4 news outlets
blogs
1 blog
twitter
77 X users
patent
5 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
699 Dimensions

Readers on

mendeley
446 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
Published in
Journal of Clinical Oncology, March 2016
DOI 10.1200/jco.2016.66.6552
Pubmed ID
Authors

Eric Bouffet, Valérie Larouche, Brittany B Campbell, Daniele Merico, Richard de Borja, Melyssa Aronson, Carol Durno, Joerg Krueger, Vanja Cabric, Vijay Ramaswamy, Nataliya Zhukova, Gary Mason, Roula Farah, Samina Afzal, Michal Yalon, Gideon Rechavi, Vanan Magimairajan, Michael F Walsh, Shlomi Constantini, Rina Dvir, Ronit Elhasid, Alyssa Reddy, Michael Osborn, Michael Sullivan, Jordan Hansford, Andrew Dodgshun, Nancy Klauber-Demore, Lindsay Peterson, Sunil Patel, Scott Lindhorst, Jeffrey Atkinson, Zane Cohen, Rachel Laframboise, Peter Dirks, Michael Taylor, David Malkin, Steffen Albrecht, Roy W R Dudley, Nada Jabado, Cynthia E Hawkins, Adam Shlien, Uri Tabori

X Demographics

X Demographics

The data shown below were collected from the profiles of 77 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 446 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
Italy 2 <1%
Japan 1 <1%
France 1 <1%
Unknown 440 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 72 16%
Student > Ph. D. Student 66 15%
Other 39 9%
Student > Bachelor 39 9%
Student > Doctoral Student 34 8%
Other 94 21%
Unknown 102 23%
Readers by discipline Count As %
Medicine and Dentistry 144 32%
Biochemistry, Genetics and Molecular Biology 64 14%
Agricultural and Biological Sciences 32 7%
Neuroscience 22 5%
Immunology and Microbiology 20 4%
Other 41 9%
Unknown 123 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 93. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 March 2024.
All research outputs
#463,928
of 25,734,859 outputs
Outputs from Journal of Clinical Oncology
#933
of 22,220 outputs
Outputs of similar age
#8,324
of 314,519 outputs
Outputs of similar age from Journal of Clinical Oncology
#23
of 239 outputs
Altmetric has tracked 25,734,859 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,220 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.1. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 314,519 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 239 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.